0001883850-21-000009.txt : 20211119 0001883850-21-000009.hdr.sgml : 20211119 20211119175044 ACCESSION NUMBER: 0001883850-21-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211119 FILED AS OF DATE: 20211119 DATE AS OF CHANGE: 20211119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHLEIFER LEONARD S CENTRAL INDEX KEY: 0001218629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211429609 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-11-19 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001218629 SCHLEIFER LEONARD S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 President & CEO Common Stock 2021-11-19 4 M 0 239063 270.43 A 543809 D Common Stock 2021-11-19 4 F 0 173491 651.96 D 370318 D Common Stock 2021-11-19 4 M 0 281250 179.13 A 651568 D Common Stock 2021-11-19 4 F 0 185646 651.96 D 465922 D Common Stock 200000 I 2021 GRAT Common Stock 5874 I By 401(k) Plan Common Stock 21178 I By Trust Non-Qualified Stock Option (right to buy) 179.13 2021-11-19 4 M 0 281250 0.0 D 2022-12-14 Common Stock 281250 0 D Non-Qualified Stock Option (right to buy) 270.43 2021-11-19 4 M 0 239063 0.0 D 2023-12-13 Common Stock 239063 0 D These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Leonard S. Schleifer 2021-11-19